Radiopharm Theranostics Ltd (RADOA) Income Statement & Earnings

0.002
0.0000.00%

20min DelayTrading Jan 14 10:29 AET

0Market Cap0.00P/E (Static)

Radiopharm Theranostics Ltd (RADOA) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2025

(FY)Jun 30, 2024

(FY)Jun 30, 2023

(FY)Jun 30, 2022

Total revenue

1,114.27%3.63M

2.35%299.23K

3,210.60%292.36K

8.83K

Operating revenue

1,114.27%3.63M

2.35%299.23K

3,210.60%292.36K

--8.83K

Cost of revenue

3.59M

Gross profit

-86.87%39.28K

2.35%299.23K

3,210.60%292.36K

8.83K

Operating expense

-7.45%34.68M

17.17%37.47M

60.52%31.98M

19.93M

Selling and administrative expenses

5.45%16.53M

2.68%15.67M

36.12%15.26M

--11.21M

-General and administrative expense

5.45%16.53M

2.68%15.67M

36.12%15.26M

--11.21M

Research and development costs

19.18%27.52M

2.01%23.09M

448.68%22.63M

--4.12M

Depreciation amortization depletion

-2.69%7.33K

14.97%7.53K

-99.78%6.55K

--2.98M

-Depreciation and amortization

-2.69%7.33K

14.97%7.53K

-99.78%6.55K

--2.98M

Other operating expenses

-624.80%-9.37M

78.16%-1.29M

-468.28%-5.92M

--1.61M

Operating profit

6.81%-34.64M

-17.30%-37.17M

-59.12%-31.69M

-19.92M

Net non-operating interest income (expenses)

247.60%333.11K

-482.88%-225.69K

100.63%58.94K

-9.35M

Non-operating interest income

1,659.36%888.2K

-65.19%50.48K

--145.04K

----

Non-operating interest expense

-89.84%65.3K

646.75%642.89K

-99.08%86.09K

--9.35M

Total other finance cost

233.56%489.79K

---366.72K

----

Other net income (expenses)

62.39%-3.93M

-255.37%-10.45M

-186.00%-2.94M

-1.03M

Gain on sale of security

45.47%138.14K

136.91%94.96K

74.99%-257.25K

---1.03M

Special income (charges)

61.42%-4.07M

-292.96%-10.55M

---2.68M

----

-Less:Restructuring and mergern&acquisition

-54.07%4.07M

230.08%8.86M

--2.68M

----

-Less:Impairment of capital assets

----

-52.29%1.48M

--3.1M

----

-Gain on sale of property,plant,equipment

--0

---1.69M

--0

----

Other non-operating income (expenses)

----

-227.89%-7.57M

--5.92M

----

Income before tax

20.09%-38.24M

-38.41%-47.85M

-14.12%-34.57M

-30.29M

Income tax

7.19%103.29K

153.56%96.36K

-14.40%38.01K

44.4K

Earnings from equity interest net of tax

Net income

20.04%-38.34M

-38.54%-47.95M

-14.08%-34.61M

-30.34M

Net income continuous operations

20.04%-38.34M

-38.54%-47.95M

-14.08%-34.61M

---30.34M

Noncontrolling interests

Net income attributable to the company

20.04%-38.34M

-38.54%-47.95M

-14.08%-34.61M

-30.34M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

20.04%-38.34M

-38.54%-47.95M

-14.08%-34.61M

-30.34M

Diluted earnings per share

Basic earnings per share

Dividend per share

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Jun 30, 2025	(FY)Jun 30, 2024	(FY)Jun 30, 2023	(FY)Jun 30, 2022
Total revenue	1,114.27%3.63M	2.35%299.23K	3,210.60%292.36K	8.83K
Operating revenue	1,114.27%3.63M	2.35%299.23K	3,210.60%292.36K	--8.83K
Cost of revenue	3.59M	0	0
Gross profit	-86.87%39.28K	2.35%299.23K	3,210.60%292.36K	8.83K
Operating expense	-7.45%34.68M	17.17%37.47M	60.52%31.98M	19.93M
Selling and administrative expenses	5.45%16.53M	2.68%15.67M	36.12%15.26M	--11.21M
-General and administrative expense	5.45%16.53M	2.68%15.67M	36.12%15.26M	--11.21M
Research and development costs	19.18%27.52M	2.01%23.09M	448.68%22.63M	--4.12M
Depreciation amortization depletion	-2.69%7.33K	14.97%7.53K	-99.78%6.55K	--2.98M
-Depreciation and amortization	-2.69%7.33K	14.97%7.53K	-99.78%6.55K	--2.98M
Other operating expenses	-624.80%-9.37M	78.16%-1.29M	-468.28%-5.92M	--1.61M
Operating profit	6.81%-34.64M	-17.30%-37.17M	-59.12%-31.69M	-19.92M
Net non-operating interest income (expenses)	247.60%333.11K	-482.88%-225.69K	100.63%58.94K	-9.35M
Non-operating interest income	1,659.36%888.2K	-65.19%50.48K	--145.04K	----
Non-operating interest expense	-89.84%65.3K	646.75%642.89K	-99.08%86.09K	--9.35M
Total other finance cost	233.56%489.79K	---366.72K	----	----
Other net income (expenses)	62.39%-3.93M	-255.37%-10.45M	-186.00%-2.94M	-1.03M
Gain on sale of security	45.47%138.14K	136.91%94.96K	74.99%-257.25K	---1.03M
Special income (charges)	61.42%-4.07M	-292.96%-10.55M	---2.68M	----
-Less:Restructuring and mergern&acquisition	-54.07%4.07M	230.08%8.86M	--2.68M	----
-Less:Impairment of capital assets	----	-52.29%1.48M	--3.1M	----
-Gain on sale of property,plant,equipment	--0	---1.69M	--0	----
Other non-operating income (expenses)	----	-227.89%-7.57M	--5.92M	----
Income before tax	20.09%-38.24M	-38.41%-47.85M	-14.12%-34.57M	-30.29M
Income tax	7.19%103.29K	153.56%96.36K	-14.40%38.01K	44.4K
Earnings from equity interest net of tax
Net income	20.04%-38.34M	-38.54%-47.95M	-14.08%-34.61M	-30.34M
Net income continuous operations	20.04%-38.34M	-38.54%-47.95M	-14.08%-34.61M	---30.34M
Noncontrolling interests
Net income attributable to the company	20.04%-38.34M	-38.54%-47.95M	-14.08%-34.61M	-30.34M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	20.04%-38.34M	-38.54%-47.95M	-14.08%-34.61M	-30.34M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"